| Meryl Levya Goldstein, MD PHD | |
|
509 Biltmore Ave, Asheville, NC 28801-4601 | |
| (828) 253-0762 | |
| (828) 254-4892 |
| Full Name | Meryl Levya Goldstein |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 33 Years |
| Location | 509 Biltmore Ave, Asheville, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265482137 | NPI | - | NPPES |
| 891214E | Medicaid | NC | |
| 1214E | Other | NC | BCBS NC |
| 220029036 | Other | NC | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZC0500X | Pathology - Cytopathology | 09900057 (North Carolina) | Secondary |
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 09900057 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Mission Hospital And Asheville Surgery Ce | Asheville, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mountain Area Pathology Pa | 2567490832 | 12 |
News Archive
United Therapeutics Corporation (NASDAQ: UTHR) announced today that Medtronic, Inc. (NYSE: MDT) has submitted a pre-market approval application to the U.S. Food and Drug Administration (FDA) for the use of Medtronic's SynchroMed® II implantable drug infusion system (including a newly developed catheter) for use with United Therapeutics' Remodulin® (treprostinil) Injection delivered intravenously to patients with pulmonary arterial hypertension.
Writing in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Joe Cerrell, director of the foundation's Europe office, and David Ferreira, managing director for innovative finance and head of the Washington, D.C., office at the GAVI Alliance, examine the benefits of investing in vaccines, stating, "Funding and supporting the delivery of life-saving vaccines is one proven way that the private sector can obtain measurable, long-term, and extremely cost-effective results."
Children and teenagers with even mild cases of anorexia exhibit abnormal bone structure, according to a new study appearing in the December issue of Radiology and presented at the annual meeting of the Radiological Society of North America (RSNA).
It is possible to have breaks in long-term medication against hormone-sensitive breast cancer - without the effect of the treatment appearing to have been influenced. Women also feel better if they take a three-month break from the hormone treatment each year, according to a medication study reported in The Lancet.
The problems of living with bipolar have been well documented, but a new study by Lancaster University has captured the views of those who also report highly-valued, positive experiences of living with the condition.
› Verified 4 days ago
| Entity Name | Mountain Area Pathology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386600054 PECOS PAC ID: 2567490832 Enrollment ID: O20050728000314 |
News Archive
United Therapeutics Corporation (NASDAQ: UTHR) announced today that Medtronic, Inc. (NYSE: MDT) has submitted a pre-market approval application to the U.S. Food and Drug Administration (FDA) for the use of Medtronic's SynchroMed® II implantable drug infusion system (including a newly developed catheter) for use with United Therapeutics' Remodulin® (treprostinil) Injection delivered intravenously to patients with pulmonary arterial hypertension.
Writing in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Joe Cerrell, director of the foundation's Europe office, and David Ferreira, managing director for innovative finance and head of the Washington, D.C., office at the GAVI Alliance, examine the benefits of investing in vaccines, stating, "Funding and supporting the delivery of life-saving vaccines is one proven way that the private sector can obtain measurable, long-term, and extremely cost-effective results."
Children and teenagers with even mild cases of anorexia exhibit abnormal bone structure, according to a new study appearing in the December issue of Radiology and presented at the annual meeting of the Radiological Society of North America (RSNA).
It is possible to have breaks in long-term medication against hormone-sensitive breast cancer - without the effect of the treatment appearing to have been influenced. Women also feel better if they take a three-month break from the hormone treatment each year, according to a medication study reported in The Lancet.
The problems of living with bipolar have been well documented, but a new study by Lancaster University has captured the views of those who also report highly-valued, positive experiences of living with the condition.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Meryl Levya Goldstein, MD PHD Po Box 419, Sylva, NC 28779-0419 Ph: (828) 366-1150 | Meryl Levya Goldstein, MD PHD 509 Biltmore Ave, Asheville, NC 28801-4601 Ph: (828) 253-0762 |
News Archive
United Therapeutics Corporation (NASDAQ: UTHR) announced today that Medtronic, Inc. (NYSE: MDT) has submitted a pre-market approval application to the U.S. Food and Drug Administration (FDA) for the use of Medtronic's SynchroMed® II implantable drug infusion system (including a newly developed catheter) for use with United Therapeutics' Remodulin® (treprostinil) Injection delivered intravenously to patients with pulmonary arterial hypertension.
Writing in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Joe Cerrell, director of the foundation's Europe office, and David Ferreira, managing director for innovative finance and head of the Washington, D.C., office at the GAVI Alliance, examine the benefits of investing in vaccines, stating, "Funding and supporting the delivery of life-saving vaccines is one proven way that the private sector can obtain measurable, long-term, and extremely cost-effective results."
Children and teenagers with even mild cases of anorexia exhibit abnormal bone structure, according to a new study appearing in the December issue of Radiology and presented at the annual meeting of the Radiological Society of North America (RSNA).
It is possible to have breaks in long-term medication against hormone-sensitive breast cancer - without the effect of the treatment appearing to have been influenced. Women also feel better if they take a three-month break from the hormone treatment each year, according to a medication study reported in The Lancet.
The problems of living with bipolar have been well documented, but a new study by Lancaster University has captured the views of those who also report highly-valued, positive experiences of living with the condition.
› Verified 4 days ago
Dr. Jeffrey Ross Embrey, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 10 Medical Park Dr, Asheville, NC 28803 Phone: 828-210-1792 | |
Joseph Patrick Sleater, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 509 Biltmore Ave, Pathology Dept, Asheville, NC 28801 Phone: 828-253-0762 Fax: 828-254-4892 | |
Harold Chalmers Poston Jr., MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 509 Biltmore Ave, Pathology Dept, Asheville, NC 28801 Phone: 828-253-0763 | |
Richard L Landau, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 509 Biltmore Ave, Pathology Dept, Asheville, NC 28801 Phone: 828-253-0763 | |
Doreen C Griswold, MD Pathology Medicare: Medicare Enrolled Practice Location: 1100 Tunnel Rd, Asheville, NC 28805 Phone: 828-298-7911 | |
Stacey Lynn Neal, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 509 Biltmore Ave, Pathology Dept, Asheville, NC 28801 Phone: 828-253-0763 |